Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy

Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy

Giuseppe Argenziano,1,* Paolo Amerio,2 Maria Grazia Aragone,3 Ginevra Baggini,4 Manuela Baldari,5 Gianpiero Castelli,6 Simmaco Coppola,7 Antonio Costanzo,8,9 Rocco De Pasquale,10 Maria Concetta Fargnoli,11 Caterina Foti,12 Claudia Giofrè,13 Serena Lembo,14 Claudia Leporati,15,16 Francesco...

Full description

Saved in:
Bibliographic Details
Main Authors: Argenziano G, Amerio P, Aragone MG, Baggini G, Baldari M, Castelli G, Coppola S, Costanzo A, De Pasquale R, Fargnoli MC, Foti C, Giofrè C, Lembo S, Leporati C, Loconsole F, Malara G, Peris K, Richetta AG, Savoia P, Tiberio R, Travaglini M, Uzzauto MT, Bianchi L
Format: article
Language:EN
Published: Dove Medical Press 2021
Subjects:
dermatology
psolife care program
quality of life
treatment adherence
Medicine (General)
R5-920
Online Access:https://doaj.org/article/c4a24d587ebb4a109ffacd9b7187f80d
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/c4a24d587ebb4a109ffacd9b7187f80d

Similar Items